Lurasidone in adolescents with schizophrenia: Sustained remission and recovery during 2 years of open-label treatment

por Tocco, M., Pikalov, A., Deng, L., Goldman, R.
Publicado 2021

Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: Pooled analysis of double-blind, placebo-controlled 6-week studies

por Calisti, F., Costamagna, I., Hsu, J., Tocco, M., Pikalov, A., Goldman, R.
Publicado 2021

Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study

por Muzina, D J, Momah, C, Eudicone, J M, Pikalov, A, McQuade, R D, Marcus, R N, Sanchez, R, Carlson, B X
Publicado 2008